Annual Operating Expenses
$59.67 M
+$2.62 M+4.60%
December 31, 2023
Summary
- As of February 8, 2025, OVID annual total operating expenses is $59.67 million, with the most recent change of +$2.62 million (+4.60%) on December 31, 2023.
- During the last 3 years, OVID annual operating expenses has fallen by -$34.37 million (-36.55%).
- OVID annual operating expenses is now -36.55% below its all-time high of $94.05 million, reached on December 31, 2020.
Performance
OVID Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$13.40 M
-$7.29 M-35.23%
September 30, 2024
Summary
- As of February 8, 2025, OVID quarterly total operating expenses is $13.40 million, with the most recent change of -$7.29 million (-35.23%) on September 30, 2024.
- Over the past year, OVID quarterly operating expenses has dropped by -$4.93 million (-26.90%).
- OVID quarterly operating expenses is now -60.89% below its all-time high of $34.26 million, reached on March 31, 2017.
Performance
OVID Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
OVID Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +4.6% | -26.9% |
| 3 y3 years | -36.5% | -26.9% |
| 5 y5 years | +12.7% | -26.9% |
OVID Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -29.1% | +4.6% | -49.1% | +10.4% |
| 5 y | 5-year | -36.5% | +4.6% | -57.9% | +14.7% |
| alltime | all time | -36.5% | +352.4% | -60.9% | +260.7% |
Ovid Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $13.40 M(-35.2%) |
| Jun 2024 | - | $20.69 M(+17.8%) |
| Mar 2024 | - | $17.57 M(-4.2%) |
| Dec 2023 | $59.67 M(+4.6%) | $18.33 M(+51.0%) |
| Sep 2023 | - | $12.14 M(-14.8%) |
| Jun 2023 | - | $14.25 M(-4.8%) |
| Mar 2023 | - | $14.96 M(+22.4%) |
| Dec 2022 | $57.05 M(-32.2%) | $12.22 M(-4.7%) |
| Sep 2022 | - | $12.82 M(-10.4%) |
| Jun 2022 | - | $14.30 M(-19.2%) |
| Mar 2022 | - | $17.71 M(-32.8%) |
| Dec 2021 | $84.17 M(-10.5%) | $26.35 M(+125.6%) |
| Sep 2021 | - | $11.68 M(-18.4%) |
| Jun 2021 | - | $14.31 M(-55.0%) |
| Mar 2021 | - | $31.82 M(+16.6%) |
| Dec 2020 | $94.05 M | $27.29 M(+17.1%) |
| Sep 2020 | - | $23.32 M(+0.8%) |
| Jun 2020 | - | $23.14 M(+14.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $20.29 M(+17.5%) |
| Dec 2019 | $61.41 M(+16.0%) | $17.27 M(+3.0%) |
| Sep 2019 | - | $16.77 M(+25.8%) |
| Jun 2019 | - | $13.32 M(-5.2%) |
| Mar 2019 | - | $14.05 M(+7.1%) |
| Dec 2018 | $52.93 M(-18.6%) | $13.13 M(-0.4%) |
| Sep 2018 | - | $13.18 M(-0.3%) |
| Jun 2018 | - | $13.21 M(-1.6%) |
| Mar 2018 | - | $13.43 M(+21.6%) |
| Dec 2017 | $65.01 M(+188.5%) | $11.05 M(+17.4%) |
| Sep 2017 | - | $9.41 M(-8.5%) |
| Jun 2017 | - | $10.29 M(-70.0%) |
| Mar 2017 | - | $34.26 M(+351.5%) |
| Dec 2016 | $22.54 M(+70.8%) | $7.59 M(+30.5%) |
| Sep 2016 | - | $5.81 M(+7.4%) |
| Jun 2016 | - | $5.42 M(+45.8%) |
| Mar 2016 | - | $3.71 M |
| Dec 2015 | $13.19 M | - |
FAQ
- What is Ovid Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Ovid Therapeutics?
- What is Ovid Therapeutics annual operating expenses year-on-year change?
- What is Ovid Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Ovid Therapeutics?
- What is Ovid Therapeutics quarterly operating expenses year-on-year change?
What is Ovid Therapeutics annual total operating expenses?
The current annual operating expenses of OVID is $59.67 M
What is the all time high annual operating expenses for Ovid Therapeutics?
Ovid Therapeutics all-time high annual total operating expenses is $94.05 M
What is Ovid Therapeutics annual operating expenses year-on-year change?
Over the past year, OVID annual total operating expenses has changed by +$2.62 M (+4.60%)
What is Ovid Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of OVID is $13.40 M
What is the all time high quarterly operating expenses for Ovid Therapeutics?
Ovid Therapeutics all-time high quarterly total operating expenses is $34.26 M
What is Ovid Therapeutics quarterly operating expenses year-on-year change?
Over the past year, OVID quarterly total operating expenses has changed by -$4.93 M (-26.90%)